Latest Research

Probiotics Reduce Diarrhea In Cancer Patients Receiving Chemotherapy

Google+ Pinterest LinkedIn Tumblr

Probiotics significantly improve chemotherapy-induced diarrhea, a common and often severe side effect of chemotherapy drugs, which can threaten the effectiveness of treatment. The study included 291 patients undergoing chemotherapy (Fluropyrimidines and/or Irinotecan specifically) -145 participants received a twice-daily dose of a high potency probiotic powder and 146 participants received a placebo powder twice daily. Treatment began 14 days before chemotherapy and continued 2 weeks following the third cycle of chemo. Results showed successful reduction in incidence of diarrhea (mild to moderate) and in patient inflammatory patterns. European Society for Medical Oncology 

Takeaway: This study shows promising results from a high potency, multi-strain probiotic in reducing diarrhea in cancer patients receiving chemotherapy. Hopefully this will result in a better quality of life, a more balanced microbiome, reduction in sickness and death related to diarrhea, and more effective cancer treatment. However, probiotics are living organisms and can be problematic in immunocompromised patients, including some cancer patients, so researchers caution that adverse side effects must be closely monitored in this population. 

Gutbliss

Founded by Dr. Robynne Chutkan, integrative gastroenterologist, bestselling author, and microbiome expert, we are your complete guide to gut health - delivered biweekly to your inbox. From the latest research on the microbiome to the best in gut-derived beauty. Sign up today - because all disease begins in the gut!

Comments are closed.